KR20030034273A - A composite of aroma therapy made of Lavender and Marjoram - Google Patents
A composite of aroma therapy made of Lavender and Marjoram Download PDFInfo
- Publication number
- KR20030034273A KR20030034273A KR1020010055080A KR20010055080A KR20030034273A KR 20030034273 A KR20030034273 A KR 20030034273A KR 1020010055080 A KR1020010055080 A KR 1020010055080A KR 20010055080 A KR20010055080 A KR 20010055080A KR 20030034273 A KR20030034273 A KR 20030034273A
- Authority
- KR
- South Korea
- Prior art keywords
- oil
- marjoram
- lavender
- weight
- composition
- Prior art date
Links
- 240000000783 Origanum majorana Species 0.000 title claims abstract description 18
- 235000011203 Origanum Nutrition 0.000 title claims abstract description 17
- 244000178870 Lavandula angustifolia Species 0.000 title claims abstract description 9
- 235000010663 Lavandula angustifolia Nutrition 0.000 title claims abstract description 9
- 239000001102 lavandula vera Substances 0.000 title claims abstract description 9
- 235000018219 lavender Nutrition 0.000 title claims abstract description 9
- 238000000222 aromatherapy Methods 0.000 title 1
- 239000002131 composite material Substances 0.000 title 1
- 239000003921 oil Substances 0.000 claims abstract description 31
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 239000000341 volatile oil Substances 0.000 claims abstract description 12
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 claims abstract description 5
- 239000010671 sandalwood oil Substances 0.000 claims abstract description 5
- 235000019198 oils Nutrition 0.000 claims description 29
- 239000003205 fragrance Substances 0.000 claims description 16
- 238000002560 therapeutic procedure Methods 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000010628 chamomile oil Substances 0.000 claims description 2
- 235000019480 chamomile oil Nutrition 0.000 claims description 2
- 239000002075 main ingredient Substances 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 abstract description 8
- 238000011282 treatment Methods 0.000 abstract description 5
- 235000007866 Chamaemelum nobile Nutrition 0.000 abstract description 4
- 244000042664 Matricaria chamomilla Species 0.000 abstract description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 abstract description 4
- 208000019116 sleep disease Diseases 0.000 abstract description 4
- 244000182022 Salvia sclarea Species 0.000 abstract description 2
- 235000002911 Salvia sclarea Nutrition 0.000 abstract description 2
- 230000002411 adverse Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000022925 sleep disturbance Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 description 6
- 230000036506 anxiety Effects 0.000 description 6
- 230000001914 calming effect Effects 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 238000001256 steam distillation Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 230000003340 mental effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 244000179970 Monarda didyma Species 0.000 description 2
- 235000010672 Monarda didyma Nutrition 0.000 description 2
- 240000000513 Santalum album Species 0.000 description 2
- 235000008632 Santalum album Nutrition 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000013200 Stress disease Diseases 0.000 description 2
- 206010043268 Tension Diseases 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000003938 response to stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 235000006297 Origanum majorana Nutrition 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000010485 coping Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 239000001780 majorana hortensis moench (origanum majorana l.) Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000001706 olfactory mucosa Anatomy 0.000 description 1
- 210000000196 olfactory nerve Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 향치료제의 사용되는 에센셜 오일에 관한것으로, 특히 라벤다(Lavender)와 마죠람(Marjoram)을 혼합 조성하여 각 조성물이 가지고 있는 고유효능이 복합 되면서 치료 효과가 상승되므로 항스트레스 및 수면촉진효과가 있도록 한 라벤다와 마죠람을 주원료로한 향치료제의 조성물에 관한 것이다.The present invention relates to essential oils used in fragrance therapy, and in particular, by combining a combination of lavender (Lavender) and marjoram (Marjoram), the inherent efficacy of each composition is combined with the anti-stress and sleep promoting effect It relates to the composition of the fragrance therapy with the main ingredients such as lavender and marjoram.
일반적으로 향치료를 위하여 식물에서 추출되는 물질들 중에 휘발성이면서 독특한 향을 발산하는 에센셜 오일 성분을 이용하여 질병을 예방하고 치료하는 자연의학적치료 방법이 오래전부터 널리 알려져 있다.In general, natural medical treatment methods for preventing and treating diseases by using essential oils that emit volatile and unique fragrance among substances extracted from plants for fragrance therapy have been widely known for a long time.
오래전부터 살균소독, 피부미용, 향수제조등 다양한 용도로 사용되어온 에센셜오일은 천연식물성 방향물질이 인체의 중추신경계와 피부세포를 통해 정신기능은 물론, 피부 및 내부기관의 기능에 작용하여 다양한 치료효과를 나타내고 있음이 많은 연구에 의하여 밝혀지고 있다.Essential oils, which have been used for various purposes such as disinfection, skin care, and perfume manufacturing for a long time, have various therapeutic effects because natural plant aromatic substances act on the functions of mental and skin and internal organs through the central nervous system and skin cells of the human body. Many studies have revealed that.
에센셜오일은 인공합성물질로는 흉내낼 수 없는 수백개의 천연물질로 이루어져 있으며, 현재 알려져 있는 30%정도의 성분만으로도 인체에 작용되어 강력하고특이한 효능을 나타낸다.Essential oils consist of hundreds of natural substances that cannot be simulated by artificial synthetic materials, and only 30% of the ingredients known to the body act on the human body to show strong and specific effects.
식물의 생물화학적 구조상 에센셜오일은 그 식물의 중추적 역할과 기능을 담당하여 세포사이에 존재하는 호르몬과 같은 역할을 하며, 생리적 기능을 조절하고 정보를 전달하는 일을한다. 즉 식물이 자신을 해충이나 질병으로 부터 보호하고 스트레스 상황에 대처하여 환경에 적응하는 물질이라고 할 수 있다.Essential oils play a pivotal role and function in the plant's biochemical structure, acting like hormones present between cells, regulating physiological functions and transmitting information. In other words, plants can protect themselves from pests and diseases, and adapt to the environment by coping with stressful situations.
이러한 에센셜오일을 인체에 흡수시키면 다양한 반응을 일으킨다.Absorption of these essential oils into the human body causes various reactions.
특히 향입자가 코점막의 실리아에 접속되어 후각신경을 거쳐 대뇌변역계로 이어지는 후각신경 변역계축은 정신 기능을 강화시켜 주거나 또는 진정 이완상태등을 만들어 주어 스트레스에 대처할 수 있도록 한다.In particular, the olfactory mucosa is connected to the cilia of the nasal mucosa through the olfactory nerve and leads to the cerebral metabolic system, which helps to cope with stress by strengthening mental function or creating a calming state.
200종 이상에 달하는 에션셜 오일 중에 원하는 정신기능과 피부상태등을 가장 효과적으로 발현시킬 수 있는 종류를 선택하여 사용하며, 이때 한가지 오일 보다는 2∼3가지 오일을 혼합하여 사용하면 치료효과를 상승시킬 수 있다.Among the more than 200 kinds of essential oils, the most effective expression of the desired mental function and skin condition is selected and used.In this case, it is possible to increase the therapeutic effect by mixing two or three oils rather than one oil. .
그러나, 상기와 같이 2∼3가지 오일을 혼합하여 사용하는 방법은 그 효과가 인정되면서도 각 오일이 가지고 있는 고유성분이 인체에 작용할 때에 지나치게 과다하거나 미흡한 것을 방지하기 위하여 혼합되는 각 오일의 양을 적절히 조절하여야 되나, 종래에는 각 오일의 함량을 개략적으로 1방울 또는 2방울등의 단위로 혼합하므로서 적절한 오일의 혼합양을 조절할 수 없었다.However, the method using a mixture of two or three oils as described above, while the effect is recognized, the amount of each oil to be mixed properly to prevent excessive or insufficient when the intrinsic components of each oil act on the human body properly Although it should be adjusted, conventionally it was not possible to adjust the appropriate amount of oil mixing by mixing the content of each oil in a unit such as roughly 1 drop or 2 drops.
때문에, 상기와같이 2∼3가지 오일의 혼합하면 그 효가가 상승됨에도 불구하고 부작용과 효능저하등의 염려가 있어 오일의 혼합사용을 꺼리는 실정이었다.Therefore, when the two or three kinds of oils are mixed as described above, there is a concern such as side effects and deterioration of efficacy even though the effectiveness thereof is increased.
특히 여러가지 증세가 나타나는 복잡한 현상의 스트레스나 수면장애에는 그효능이 부족한 실정이었다.In particular, the stress or sleep disorders of complex symptoms appearing various symptoms were lacking in their effectiveness.
본 발명은 상기한 문제를 해결하기 위하여, 연구개발된 것으로서,The present invention has been researched and developed in order to solve the above problems,
라벤다와 마죠람을 혼합조성하여 치료효과가 상승되도록 하는데 그 기술적 과제가 있다.There is a technical problem in that a combination of lavender and marjoram to increase the therapeutic effect.
본 발명의 다른 기술적 과제는 여러 종류의 에센셜오일을 혼합조성함에 있어 각각의 오일이 갖고 있는 고유효능을 상승시키면서 부작용이 제거되도록 하는데 있다.Another technical problem of the present invention is to increase the inherent efficacy of each oil in the composition of the composition of the various essential oils to eliminate side effects.
본 발명의 또 다른 기술적 과제는 질병의 종류에 따라 다양한 효능이 발휘되는 에센셜오일을 혼합하여 스트레스 및 수면장애를 다양한 각도에서 치료 및 예방할 수 있도록 하는데 있다.Another technical problem of the present invention is to mix and treat essential oils exhibiting various effects according to the type of disease to be able to treat and prevent stress and sleep disorders from various angles.
본 발명은 다수의 에센셜오일이 혼합된 공지의 향 치료제에 있어서, 전체 중량비로서 라벤다오일 45∼60%, 마죠람오일 20∼40%와 기타 오일을 혼합조성하는 것이다.According to the present invention, in the known fragrance treatment agent in which a plurality of essential oils are mixed, 45 to 60% of lavender oil, 20 to 40% of marjoram oil, and other oils are mixed as a total weight ratio.
상기 라벤다 오일은 라벤다 나무의 꽃이 핀 선단부와 잎에서 수증기 증류법으로 추출된 것으로서, 대단히 다양한 정신 및 신체작용을 발휘하여 균형과 조화를 이루게 하는 향이며, 정신적 피로를 회복시켜 주고 진통과 방부효과도 뛰어 날뿐 아니라, 불안, 우울한 감정을 해소시키고 편안한 수면을 유도하는 효능이 있다.The lavender oil is extracted by steam distillation from the flowers and the tip of the leaves of the lavender tree, it is a fragrance that balances and harmonizes by exerting a great variety of mental and physical actions, restores mental fatigue and also has analgesic and antiseptic effects. Not only does it excel, it also helps to relieve anxiety and depression and to induce a comfortable sleep.
특히 중추신경의 밸런스를 잡아 주는 작용이 있으므로 조울증적인 상태일때그 치료효과가 크다.In particular, the balance of the central nervous system because it is effective in treating manic depression when the effect is great.
그러나, 라벤다 오일은 저혈압인 환자중에는 감각이 둔해지거나 졸음이 오는 부작용이 있고 임신초기의 임산부에게는 사용이 제한되는 것으로서, 향치료제의 전체 중량에 대한 혼합비율이 60%를 초과하게 되면 상기 부작용이 발생될 우려가 있고 45%미만이 되면 그 효능이 저하되므로 그 함유량을 45∼60%로 하는 것이 바람직하다.However, lavender oil has a side effect of feeling dull or drowsy in patients with low blood pressure, and it is restricted to pregnant women in early pregnancy, and the side effect occurs when the mixing ratio of the total weight of the fragrance medicine exceeds 60%. If the content is less than 45%, the efficacy is lowered. Therefore, the content is preferably 45 to 60%.
상기 마죠람 오일은 스위트마죠람 초목의 잎과 꽃핀 선단부에서 수증기 증류법으로 추출되는 것으로서, 신경계를 진정시키는 효과를 나타내므로 불안과 스트레스의 영향을 완화시키고 정서를 따뜻하게 하는 효능이 있으며, 안정되지 못하고 주의를 집중시키지 못하는 환자에게 효능이 있다.The marjoram oil is extracted by steam distillation at the tip of the leaves and flower pins of sweet marjoram vegetation, and has a calming effect, so as to alleviate the effects of anxiety and stress and to warm the emotions, and not to stabilize It is effective for patients who cannot concentrate.
그러나, 마죠람오일은 장시간 사용하면 졸음이 오고 임산부에게는 사용이 제한되는 것으로서, 향치료제의 전체 중량에 대한 혼합비율이 40%를 초과하게 되면 상기 부작용이 발생될 우려가 있고 20%미만이 되면 그 효능이 저하되므로 그 함유량을 20∼40%로 하는 것이 바람직하다.However, when marjoram oil is used for a long time, drowsiness is limited and it is restricted to pregnant women. When the mixing ratio of the total weight of the fragrance medicine exceeds 40%, the side effects may occur. Since efficacy falls, it is preferable to make the content into 20 to 40%.
상기 향치료제는 라벤다 오일과 마죠람오일이외에 효능을 증진시키기 위하여 버가못(Bergamot), 산달우드(Sandalwood), 챠모마일 로만(Chamomile roman), 클라리세지(Clary sage)등의 오일이 첨가 된다.The fragrance treatment agent is added to oils such as bergamot, sandalwood, chamomile roman, clary sage in order to enhance the efficacy in addition to lavender oil and marjoram oil.
상기 버가못오일은 버가못 나무의 껍질에서 압착법으로 추출되는 것으로서, 마음을 진정시키는 성질이 있으므로 불안증, 우울증, 신경의 긴장등에 특히 효과가 있으며, 교감신경계의 활동을 완화시켜 성난 기분과 좌절감등을 제어하는 효능이있다.The bergamot oil is extracted from the bark of the bergamot tree by the compression method, so it is particularly effective for anxiety, depression, nervous tension, etc., because it has a calming nature, and controls the activity of the sympathetic nervous system to control angry mood and frustration. There is no efficacy
그러나, 버가못 오일은 사용 후 태양광에 노출될 경우 피부의 광감작용을 증대시켜 화상의 염려가 있을 뿐 아니라 피부의 민감한 부위를 자극할 염려가 있는 것으로서, 향치료제의 전제 중량에 대한 혼합비율이 25%를 초과하게 되면 상기 부작용이 노출되고 20%미만이 되면 효능이 저하되므로 그 함유량을 20∼25%로 하는 것이 바람직하다.However, bergamot oil may increase the photosensitivity of the skin when exposed to sunlight after use, which may cause burns as well as irritate sensitive areas of the skin. Exceeding% exposes the side effects and less than 20% decreases the efficacy, so the content is preferably set to 20-25%.
상기 산달우드오일은 백단목의 줄기에서 수증기 증류법으로 추출되는 것으로서 신경의 긴장과 불안을 덜어주고 기본을 진정시키는 효능이 있습니다.The sandalwood oil is extracted by steam distillation from the stem of sandalwood, and it has the effect of relieving nervous tension and anxiety and calming the basics.
그러나 산달우드 오일은 그 향이 강하고 오래가는 특성이 있고 우울증의 경우에는 부작용이 생길수 있는 것으로, 향치료제의 전체 중량에 대한 혼합비율이 10%를 초과하게 되면 상기 부작용이 노출되고 5%미만이 되면 그 효능이 저하되므로 그 함유량을 5∼10%로 하는 것이 바람직하다.However, sandalwood oil has strong scent and long-lasting characteristics and may have side effects in case of depression. If the mixing ratio of the total weight of the fragrance medicine exceeds 10%, the side effect is exposed and less than 5%. Since efficacy falls, it is preferable to make the content into 5 to 10%.
상기 챠모마일 로만오일은 마일레 약초의 꽃에서 수증기 증류법으로 추출되는 것으로서, 불안, 긴장, 분노, 공포등의 생각들을 완화시키는 작용을 하고 마음을 진정시키며 불면증에 그 효능이 있다.The chamomile roman oil is extracted by steam distillation from the flowers of the medicinal herb, it acts to alleviate anxiety, tension, anger, fear, etc., has a calming effect on the heart and insomnia.
그러나, 챠모마일 로만 오일은 통경작용이 있으므로 임산부에게 부작용이 발생될 우려가 있는 것으로, 향치료제의 전체 중대한 혼합비율이 5%를 초과하게 되면 상기 부작용이 노출되고 2%미만이 되면 그 효능이 저하되므로 그 함유량을 2∼5%로 하는것이 바람직하다.However, since chamomile roman oil has a penetrating effect, there is a risk of side effects occurring in pregnant women. Therefore, it is preferable to make the content into 2 to 5%.
상기 클라리세지 오일은 클라리세지 약초의 잎과 꽃핀 선단부에서 수증기 증류법으로 추출되는 것으로서, 긴장을 완화시키므로 신경에 탁월한 피로회복제 효능이 있다.The classage oil is extracted by steam distillation from the leaf and flower pin tip of the clasage herb, and relaxes the tension, thereby having an excellent fatigue recovery effect on nerves.
그러나 진정력이 강하여 사물에 대한 집중력이 떨어지고 알콜음료와 같이 섭취하면 구토가 발생하며 다량을 사용하면 두통의 원인이 되는것으로서,However, since the sedation is strong, the concentration on things is lowered and vomiting occurs when ingested with alcoholic beverages.
향치료제의 전체 중량에 대한 혼합비율이 6%를 초과하게 되면 상기 부작용이 노출되고 2%미만이 되면 그 효능이 저하되므로 그 함유량을 2∼6로 하는것이 바람직하다.When the mixing ratio with respect to the total weight of the flavoring agent exceeds 6%, the side effects are exposed and when the ratio is less than 2%, the efficacy is lowered, so the content thereof is preferably 2-6.
<실시예 1><Example 1>
전체 중량비로서, 라벤다오일 48%, 마죠람오일 20%에 버가못오일 22%, 산달우드오일 7%, 챠모마일로만오일 3%를 첨가한 후 혼합하여 향치료제를 제조하였다.As a total weight ratio, 48% of lavender oil, 20% of marjoram oil, 22% of bergamot oil, 7% of sandalwood oil, and 3% of chamomile oil were added, followed by mixing to prepare a flavoring agent.
상기 향 치료제는 스트레스 및 우울증, 불안등을 치료하는 용도로 사용하였으며, 이를 입증하기 위하여 다음과 같은 실험이 실시되었다.The fragrance therapy was used to treat stress, depression, anxiety, etc., and the following experiments were conducted to prove this.
방법Way
대학생 26명(남 14명, 여12명)을 대상으로 하여 ABR(Autonomic Bioelectric Response Recorder)검측기로 측정하였다.Twenty six college students (14 males and 12 females) were measured with an ABR (Autonomic Bioelectric Response Recorder) detector.
ABR은 전극을 통해 인체 각 부위(7부위로 나누었음)의 유입 전류량을 측정하고 흘러들어간 전류량의 많고 적음에 따른 저항값으로 Activity(A : 활동성), Reaction(R :반응성), Polarization(P : 대칭성)을 표시하고 이를 통해 스트레스 반응을 측정하는 기구이다.ABR measures the amount of inflow current in each part of the human body (divided into 7 parts) through the electrode, and it is a resistance value according to the amount of current flowing into it.The activity (A: Reactivity), Polarization (P :) Symmetry) to measure stress response.
본 연구에서는 향치료제에서 발산되는 향 흡입전과 후의 A, R, P를 측정하여스트레스 반응을 살펴보았다.In this study, the stress response was measured by measuring A, R, and P before and after inhalation of perfume emitted from perfume.
결과result
<표 1>에서 보는 바와같이 향 흡입전후의 반응차이에서 A(활동성)측정치 중 인체 하부에서 통계적으로 유의미한 차이를 보여 향처치로 스트레스가 감소되었음을 보여주고 있다.As shown in <Table 1>, the difference in response between before and after inhalation of aroma showed statistically significant difference in the lower part of the human body, indicating that stress was reduced by aroma treatment.
<표 1> 아모라 향 흡입전후의 평균값과 표준편차<Table 1> Mean value and standard deviation before and after inhalation of Amora
*p < 0.05 * p <0.05
<실시예 2><Example 2>
전체 중량비로서 라벤다오일 58%, 마죠람오일 28%, 클라이세지 오일 4%를 혼합하여 향치료제를 제조하였다.As a total weight ratio, 58% of lavender oil, 28% of marjoram oil, and 4% of classy oil were mixed to prepare a flavoring agent.
이러한 향 치료제는 목욕시 사용하거나 방향용으로 환자에게 제공하며, 불면증이 해소되어 수면을 촉진시키는 효과가 있다.These fragrances are used in the bath or provided to the patient for aroma, and insomnia is relieved to have an effect of promoting sleep.
상기한 바와같이 본 발명은 라벤다 오일과 마죠람 오일을 주성분으로 하여 기타오일을 첨가하여서 된 향치료제 조성물로서, 여러 종류의 오일이 각각 갖고 있는 고유효능이 상승되면서 부작용 발생이 억제 되도록 한 효과가 있는 것이다.As described above, the present invention is a fragrance therapy composition by adding other oils based on lavender oil and marjoram oil, and has an effect of suppressing the occurrence of side effects while increasing the inherent efficacy of each of various oils. will be.
또한, 스트레스나 우울증 및 수면장애등 환자의 증세에 따라 향치료제를 선택적으로 적용할 수 있을뿐 아니라, 부가되는 오일을 선택하면 다양한 방법으로 치료 및 예방효과가 있는 것이다.In addition, according to the symptoms of the patient, such as stress or depression and sleep disorders can be selectively applied as a therapeutic agent, selecting the added oil will have a therapeutic and preventive effect in a variety of ways.
본 발명은 향치료제를 환자에게 시술하는 방법이 간단하기 때문에 널리 사용하면서 건강증진에 크게 기여할 수 있는 유익한 발명인 것이다.The present invention is a beneficial invention that can greatly contribute to health promotion while widely used because the method of treating the odor therapy agent to the patient is simple.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020010055080A KR20030034273A (en) | 2001-09-07 | 2001-09-07 | A composite of aroma therapy made of Lavender and Marjoram |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020010055080A KR20030034273A (en) | 2001-09-07 | 2001-09-07 | A composite of aroma therapy made of Lavender and Marjoram |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20030034273A true KR20030034273A (en) | 2003-05-09 |
Family
ID=29561897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020010055080A KR20030034273A (en) | 2001-09-07 | 2001-09-07 | A composite of aroma therapy made of Lavender and Marjoram |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20030034273A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4125559A (en) * | 1976-06-23 | 1978-11-14 | Basf Aktiengesellschaft | Manufacture of alkali metal salts of arabonic acid |
| JPH04149135A (en) * | 1990-10-09 | 1992-05-22 | Kureha Chem Ind Co Ltd | Perfume composition and perfume product therefrom |
| KR930019228A (en) * | 1992-03-13 | 1993-10-18 | 한동근 | Humidifier with pharmacological effect |
| KR20000001148A (en) * | 1998-06-09 | 2000-01-15 | 최영신 | Essential oil composition having functions of antibiosis and antifungus |
| KR20010020067A (en) * | 1999-08-31 | 2001-03-15 | 오세군 | Composition and manufacturing method of toothpaste containing aromatherapeut ic essential oils |
| KR100688787B1 (en) * | 2005-02-23 | 2007-03-02 | 삼성전기주식회사 | Data transposing device and method for optical device using optical modulator |
-
2001
- 2001-09-07 KR KR1020010055080A patent/KR20030034273A/en not_active Application Discontinuation
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4125559A (en) * | 1976-06-23 | 1978-11-14 | Basf Aktiengesellschaft | Manufacture of alkali metal salts of arabonic acid |
| JPH04149135A (en) * | 1990-10-09 | 1992-05-22 | Kureha Chem Ind Co Ltd | Perfume composition and perfume product therefrom |
| KR930019228A (en) * | 1992-03-13 | 1993-10-18 | 한동근 | Humidifier with pharmacological effect |
| KR20000001148A (en) * | 1998-06-09 | 2000-01-15 | 최영신 | Essential oil composition having functions of antibiosis and antifungus |
| KR20010020067A (en) * | 1999-08-31 | 2001-03-15 | 오세군 | Composition and manufacturing method of toothpaste containing aromatherapeut ic essential oils |
| KR100688787B1 (en) * | 2005-02-23 | 2007-03-02 | 삼성전기주식회사 | Data transposing device and method for optical device using optical modulator |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Koulivand et al. | Lavender and the nervous system | |
| CN101732458B (en) | Compound essential oil having functions of refreshing spirit, restoring consciousness and resisting fatigue, and wet tissue containing same | |
| Robins | The science and art of aromatherapy | |
| KR20120131970A (en) | Perfume composition with antistress and relexing effect, and cosmetic composition comprising the same | |
| Farah et al. | Assessment of Valeriana officinalis l.(Valerian) for conscious sedation of patients during the extraction of impacted mandibular third molars: a randomized, split-mouth, double-blind, crossover study | |
| CN107569616A (en) | A kind of compound oil for improving sleep and preparation method thereof | |
| KR101074955B1 (en) | Perfume composition having aromatherapic effect | |
| US10245295B1 (en) | Neurological essential oil composition and methods | |
| Koriem | Lavandulae aetheroleum oil: A review on phytochemical screening, medicinal applications, and pharmacological effects | |
| CN107412589A (en) | A kind of multifunction sleeping-aid mind-tranquilizing brain-strengthening pack | |
| Anggraini et al. | Effect of aromatherapy blend essential oils (lemongrass and lemon) on sleep quality in pregnant women’s third trimester | |
| CN114129630A (en) | Preparation method and application of essential oil composition for soothing nerves, helping sleep and recovering memory | |
| CN116726131B (en) | Essential oil composition for dizziness and application thereof | |
| KR102455783B1 (en) | Natural essential oil composition with excellent sleep effect and Cosmetic composition comprising the same | |
| CN105055478A (en) | Traditional Chinese medicinal health composition and traditional Chinese medicine health pillow | |
| KR20030034273A (en) | A composite of aroma therapy made of Lavender and Marjoram | |
| WO2018189101A1 (en) | Compositions comprising essential oils for topical use | |
| Buchbauer | Lavender oil and its therapeutic properties | |
| CN109432318B (en) | Compound essential oil, application thereof and compound essential oil product | |
| KR100377319B1 (en) | Essential oil composition for curing rhinitis | |
| KR20030021699A (en) | A composite of aroma therapy made of Peppermint and Camomile roman | |
| KR20230166333A (en) | Aroma therapy oil composit and manufacturing method therof | |
| KR101416648B1 (en) | A healing band soaked with essential oils | |
| CN109602805A (en) | Passive sleeping composition and its application | |
| CN108079059A (en) | A kind of styrax compound essential oil for improvement sleep |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20010907 |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20040128 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20040413 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20040128 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |